Colorado Cannabis Recalls: Safety Standards, Testing & Consumer Protection

Executive Summary

Colorado's regulated cannabis market faces ongoing product safety challenges as contaminated marijuana continues to trigger recalls across licensed dispensaries statewide. The Colorado Marijuana Enforcement Division (MED), operating under the Department of Revenue, maintains a public recall system designed to protect consumers from products that fail mandatory testing for pesticides, heavy metals, microbial contaminants, and residual solvents. Recent recalls in May 2026 underscore persistent quality control issues within the state's seed-to-sale tracking framework, affecting both flower and concentrate products distributed through multiple retail locations. Colorado consumers can verify recall status through the MED's online database, which lists affected product batches, license numbers, and specific contaminants detected. The state's recall system represents a critical consumer protection mechanism in the nation's first adult-use cannabis market, where regulatory oversight continues to evolve nearly fourteen years after Amendment 64 legalized recreational marijuana. Understanding recall procedures, checking product batch numbers, and recognizing contamination risks remain essential for Colorado's estimated 800,000 regular cannabis consumers.

Why Colorado Cannabis Recalls Matter

Product recalls in Colorado's $1.3 billion annual cannabis market directly impact patient safety, business operations, and regulatory credibility across the nation's most established legal framework. Colorado's cannabis industry serves both medical patients and adult-use consumers through approximately 500 licensed dispensaries statewide. Medical marijuana patients—numbering roughly 78,000 registered individuals as of 2026—often rely on cannabis products to manage chronic pain, PTSD, epilepsy, and cancer-related symptoms. Contaminated products pose heightened risks for immunocompromised patients, including those undergoing chemotherapy or managing HIV/AIDS. The financial stakes extend beyond individual health concerns. A single recall can cost cultivators and processors between $50,000 and $500,000 in destroyed inventory, depending on batch size and distribution scope. Multi-state operators (MSOs) with Colorado operations face additional reputational damage when recalls occur, potentially affecting investor confidence and capital access. The state collected $423 million in marijuana tax revenue during fiscal year 2025, funding school construction, substance abuse programs, and regulatory enforcement—revenue streams that depend on maintaining consumer trust in product safety. Recalls also serve as regulatory accountability measures. The MED conducts approximately 12,000 compliance inspections annually, with recall frequency serving as a key performance indicator for the state's testing laboratory network and track-and-trace system. High recall rates can indicate systemic cultivation problems, inadequate testing protocols, or enforcement gaps requiring legislative attention. Colorado's recall system has influenced policy development in newer cannabis markets including New York, Ohio, and Pennsylvania, making the state's approach a national benchmark for product safety standards.

Background and History: Colorado's Cannabis Regulatory Evolution

Colorado's path from medical marijuana pioneer to comprehensive recall system spans three decades of regulatory development, market maturation, and safety protocol refinement.

Amendment 20 and Medical Marijuana (2000-2009)

Colorado voters approved Amendment 20 in November 2000, establishing the state's medical marijuana program with 54% support. The constitutional amendment allowed patients with debilitating conditions to possess up to two ounces of usable cannabis and cultivate six plants. The initial framework lacked commercial licensing provisions, operating primarily as a patient-caregiver model with minimal state oversight. The Colorado Department of Public Health and Environment (CDPHE) administered the medical registry but provided no product testing requirements or quality standards during this early period. Patients obtained medicine through informal caregiver relationships or home cultivation, with no mandatory laboratory analysis for contaminants. This regulatory gap persisted until 2009, when the Obama administration's Ogden Memo signaled federal non-interference in state medical marijuana programs, triggering rapid commercial expansion.

House Bill 1284 and Commercial Licensing (2010-2012)

The Colorado General Assembly passed House Bill 10-1284 in 2010, creating the nation's first comprehensive medical marijuana licensing system. The legislation established the Medical Marijuana Enforcement Division within the Department of Revenue, implementing seed-to-sale tracking through the METRC system and mandatory business licensing for cultivation facilities, infused product manufacturers, and dispensaries. HB 1284 introduced basic product safety requirements, including voluntary testing recommendations and sanitation standards for manufacturing facilities. However, the law stopped short of mandatory testing for all products, leaving contamination detection largely to voluntary industry practices. The MED issued its first product recall in August 2011 after a Denver dispensary voluntarily reported pesticide contamination in a batch of pre-rolled joints, establishing precedent for the recall notification system.

Amendment 64 and Adult-Use Legalization (2012-2014)

Colorado voters approved Amendment 64 in November 2012 with 55% support, making Colorado and Washington the first states to legalize adult-use cannabis. The constitutional amendment directed the General Assembly to establish licensing and regulatory frameworks for commercial recreational marijuana by July 2013. The legislature passed House Bill 13-1317 and Senate Bill 13-283 in 2013, creating parallel regulatory structures for medical and retail marijuana. The new framework maintained the Medical Marijuana Enforcement Division while establishing retail licensing categories. Crucially, the legislation included enhanced product testing requirements, though comprehensive mandatory testing for all contaminants would not take effect until 2015. Colorado's first licensed retail dispensaries opened on January 1, 2014, in Denver and other municipalities that opted into adult-use sales. The initial retail framework required testing for potency (THC and CBD content) but left pesticide, microbial, and heavy metal testing as recommended rather than mandatory practices.

Mandatory Testing Implementation (2015-2017)

The MED adopted comprehensive mandatory testing rules effective October 1, 2015, requiring all marijuana flower, concentrate, and infused products to undergo laboratory analysis before retail sale. The regulations established action levels for: - Microbial contaminants (E. coli, Salmonella, total yeast and mold) - Pesticide residues (specific action levels for 20+ compounds) - Residual solvents (butane, propane, ethanol, hexane) - Heavy metals (lead, arsenic, cadmium, mercury) The MED licensed independent testing laboratories and implemented proficiency testing requirements to ensure analytical accuracy. The agency established a public recall database accessible through the Colorado Department of Revenue website, listing all mandatory and voluntary recalls with batch numbers, license information, and contamination details. The first major recall under the new mandatory testing regime occurred in January 2016, when LivWell Enlightened Health—one of Colorado's largest dispensary chains—recalled products from multiple locations after pesticide contamination was detected. The recall affected approximately 60,000 plants and highlighted enforcement challenges in the state's track-and-trace system.

Pesticide Crisis and Enhanced Enforcement (2018-2020)

Colorado's cannabis industry faced a pesticide contamination crisis in 2018-2019, with recall frequency increasing as testing laboratories improved detection capabilities and the MED enhanced enforcement. The agency issued 23 recalls in 2018 alone, compared to 11 recalls in 2017, with pesticides accounting for approximately 70% of contamination events. The MED responded by updating its pesticide action levels in January 2019, adopting more stringent thresholds aligned with California's testing standards. The agency also implemented enhanced inspection protocols for cultivation facilities, requiring documented integrated pest management (IPM) plans and restricting the use of certain fungicides and insecticides commonly detected in recalled products. The COVID-19 pandemic in 2020 temporarily reduced recall frequency as laboratory testing backlogs developed, but also highlighted supply chain vulnerabilities. The MED designated cannabis businesses as essential services, allowing continued operations while implementing enhanced sanitation requirements for manufacturing facilities.

Recent Developments (2021-2026)

Colorado's recall system has matured into a comprehensive consumer protection framework, with the MED issuing an average of 15-20 recalls annually between 2021 and 2026. The agency launched an enhanced online recall database in March 2023, providing real-time notifications and mobile-friendly lookup tools for consumers to verify product safety by batch number. Legislative developments have continued to refine testing standards. House Bill 21-1317 expanded heavy metal testing requirements in 2021, while Senate Bill 23-1 enhanced enforcement penalties for cultivators with repeated contamination violations. The MED now maintains a tiered penalty system, with first-time violations resulting in product destruction and fines up to $10,000, while repeat offenders face license suspension or revocation. The May 2026 recalls that triggered renewed public attention involved multiple dispensaries across the Denver metropolitan area and Colorado Springs, with contaminants including unauthorized pesticides and microbial contamination exceeding action levels. These recalls demonstrate that despite regulatory maturation, product safety challenges persist in Colorado's cannabis market.

Key Players in Colorado's Recall System

Colorado Marijuana Enforcement Division (MED)

The MED serves as the primary regulatory authority responsible for licensing, inspection, testing oversight, and recall administration across Colorado's cannabis industry. Operating within the Colorado Department of Revenue, the division employs approximately 85 staff members including compliance investigators, licensing specialists, and policy analysts. The MED Director reports to the Executive Director of the Department of Revenue and implements rules adopted by the State Licensing Authority. The division maintains the METRC seed-to-sale tracking system, which monitors all cannabis products from cultivation through retail sale. When contamination is detected, the MED uses METRC data to identify affected batches, trace distribution pathways, and notify licensed retailers carrying recalled products. The agency's recall authority derives from Colorado Revised Statutes Title 44, Article 10, which grants the MED power to embargo products, order destruction of contaminated inventory, and impose administrative penalties.

Licensed Testing Laboratories

Colorado maintains approximately 15 state-licensed cannabis testing laboratories responsible for analyzing product samples before retail sale. These independent facilities must achieve ISO/IEC 17025 accreditation and pass regular proficiency testing administered by the MED. Major testing laboratories include Steep Hill Colorado, Green Leaf Lab, and Medicine Man Denver Lab. Testing laboratories serve as the first line of contamination detection, analyzing samples for potency, pesticides, microbial contaminants, heavy metals, residual solvents, and moisture content. When a sample fails testing, laboratories must report results to the MED within 24 hours, triggering the recall process. Laboratory accuracy remains critical—false negatives allow contaminated products to reach consumers, while false positives result in unnecessary product destruction and financial losses for cultivators.

Licensed Cultivators and Manufacturers

Colorado licenses approximately 1,200 cultivation facilities and 300 infused product manufacturers responsible for producing cannabis flower, concentrates, edibles, and topicals. These businesses bear primary responsibility for product safety, implementing good manufacturing practices (GMP), integrated pest management protocols, and quality control systems. When recalls occur, cultivators and manufacturers must destroy affected inventory under MED supervision, notify downstream retailers, and implement corrective action plans to prevent recurrence. Repeat contamination violations can result in license suspension, making effective quality control essential for business viability. Large MSOs including Schwazze (formerly Medicine Man Technologies) and Trulieve operate multiple Colorado facilities and have developed sophisticated internal testing and quality assurance programs to minimize recall risk.

Licensed Dispensaries

Colorado's approximately 500 licensed dispensaries serve as the consumer-facing component of the recall system. Retailers must maintain detailed inventory records through METRC, allowing rapid identification of recalled products on their shelves. When the MED issues a recall notice, dispensaries must immediately remove affected products from sale, notify customers who purchased recalled items (when transaction records allow identification), and return inventory to the originating cultivator or manufacturer for destruction. Dispensary compliance with recall procedures is monitored through MED inspections, with violations resulting in fines or license sanctions. Major dispensary chains including Native Roots, The Green Solution, and Lightshade have implemented internal tracking systems that supplement METRC, enabling faster recall response and customer notification.

Consumer Advocacy Organizations

Organizations including the Cannabis Consumers Coalition and Colorado NORML advocate for enhanced consumer protections, transparent recall reporting, and improved testing standards. These groups have successfully lobbied for legislative improvements including expanded heavy metal testing and enhanced online recall databases. Patient advocacy organizations such as Colorado Patients Alliance focus specifically on medical marijuana safety, emphasizing the heightened contamination risks for immunocompromised individuals.

Legal and Regulatory Framework

Colorado's cannabis recall system operates under a comprehensive legal framework established through constitutional amendments, state statutes, and administrative regulations. The constitutional foundation derives from Amendment 64, codified in Article XVIII, Section 16 of the Colorado Constitution, which directed the General Assembly to establish regulations for marijuana cultivation, manufacturing, testing, and sales. The amendment specifically authorized the state to adopt "regulations necessary for the protection of public health and safety." Colorado Revised Statutes Title 44, Article 10 (C.R.S. § 44-10-101 et seq.) establishes the statutory framework for marijuana regulation, granting the MED authority to adopt rules governing product safety, testing requirements, and recall procedures. Key statutory provisions include: - C.R.S. § 44-10-203: Establishes the State Licensing Authority and grants rulemaking power - C.R.S. § 44-10-306: Requires testing of marijuana and marijuana products - C.R.S. § 44-10-307: Authorizes product embargoes and recalls - C.R.S. § 44-10-701: Establishes penalties for violations including contaminated product sales The MED implements these statutory provisions through the Colorado Marijuana Rules (1 CCR 212-3), a comprehensive regulatory code exceeding 300 pages. Rule 3-710 specifically addresses product testing requirements, establishing mandatory testing for: - Potency analysis (THC, THCA, CBD, CBDA) - Microbial contamination (total yeast and mold, E. coli, Salmonella) - Pesticide residues (action levels for 40+ compounds) - Residual solvents (butane, propane, ethanol, hexane, acetone) - Heavy metals (lead, arsenic, cadmium, mercury) - Moisture content and water activity Rule 3-715 establishes recall procedures, distinguishing between mandatory recalls (ordered by the MED when contamination poses health risks) and voluntary recalls (initiated by licensees who discover quality issues). The rule requires licensees to notify the MED within 24 hours of discovering contamination, provide detailed batch information through METRC, and submit corrective action plans within 10 business days. The regulatory framework also addresses testing laboratory standards through Rule 3-705, requiring ISO/IEC 17025 accreditation, proficiency testing participation, and method validation. Laboratories must report all failed tests to the MED within 24 hours, creating the trigger mechanism for recall initiation. Enforcement authority includes administrative penalties ranging from written warnings to license revocation. The MED maintains a tiered penalty structure: first-time contamination violations typically result in product destruction and fines between $2,500 and $10,000, while repeat violations within 24 months can trigger license suspension. Criminal penalties under C.R.S. § 44-10-701 apply to knowing sales of contaminated products, with potential felony charges for violations causing serious bodily injury.

How Colorado's Recall System Works

Colorado's cannabis recall process follows a structured protocol from contamination detection through product destruction, designed to remove unsafe products from commerce within 24-48 hours. The recall process typically begins when a licensed testing laboratory detects contamination exceeding action levels during mandatory pre-sale testing. The laboratory reports the failed test to the MED within 24 hours, providing batch identification numbers, license information, and specific contaminant levels. The MED then queries the METRC system to identify all products from the affected batch, trace distribution to retail locations, and determine the scope of potential consumer exposure. The MED issues a mandatory recall order to the originating cultivator or manufacturer, requiring immediate notification to all downstream licensees who received products from the contaminated batch. Retailers must remove affected products from shelves within 24 hours and post recall notices in visible locations. The MED simultaneously updates its public recall database, listing the product name, batch number, affected license numbers, specific contaminant, and detection date. Consumers who purchased recalled products can return them to the dispensary for refund or replacement, though Colorado law does not mandate refunds for recalled cannabis products (unlike conventional consumer goods). Dispensaries typically offer refunds as a business practice to maintain customer relationships, but legal requirements focus on removal from sale rather than consumer compensation. The originating licensee must destroy all recalled inventory under MED supervision, documenting destruction through METRC and photographic evidence. Destruction typically occurs through grinding and composting for flower products, or incineration for concentrates and infused products. The licensee must submit a corrective action plan within 10 business days, detailing root cause analysis and preventive measures to avoid recurrence. The MED conducts follow-up inspections to verify destruction, review corrective actions, and assess whether additional enforcement is warranted. Repeat contamination violations trigger escalating penalties, including increased fines, mandatory third-party audits, and potential license suspension. Consumers can check recall status through the MED's online database at colorado.gov/pacific/enforcement/med-marijuana-recalls, which allows searches by product name, batch number, or license number. The database includes recalls dating back to 2015, providing historical transparency on contamination patterns and affected businesses.

Common Contamination Types and Health Risks

Colorado cannabis recalls primarily involve four contamination categories: pesticides, microbial contaminants, heavy metals, and residual solvents, each posing distinct health risks. Pesticide contamination accounts for approximately 60% of Colorado cannabis recalls. Commonly detected compounds include myclobutanil (a fungicide that converts to hydrogen cyanide when combusted), imidacloprid (a neonicotinoid insecticide), and bifenazate (an acaricide). These pesticides are not approved for use on cannabis by the Environmental Protection Agency (EPA), and their presence indicates unauthorized application during cultivation. Health risks include respiratory irritation, neurological effects, and potential carcinogenic exposure, with heightened risks for immunocompromised patients. Microbial contamination represents approximately 25% of recalls, involving total yeast and mold counts exceeding 10,000 colony-forming units per gram (CFU/g), or detection of pathogenic bacteria including E. coli and Salmonella. Aspergillus species pose particular risks for immunocompromised patients, potentially causing invasive aspergillosis—a serious fungal infection affecting the lungs. Microbial contamination typically results from inadequate drying and curing practices, poor storage conditions, or contaminated water sources during cultivation. Heavy metal contamination accounts for approximately 10% of recalls, with lead being the most frequently detected metal exceeding action levels. Cannabis plants bioaccumulate heavy metals from contaminated soil, water, or fertilizers, with concentrations increasing during extraction processes for concentrates. Lead exposure poses developmental risks for children and pregnant women, while chronic exposure can cause neurological damage in adults. Arsenic, cadmium, and mercury are also monitored, with action levels set at 1.2 parts per million (ppm), 0.82 ppm, and 0.62 ppm respectively for inhalable products. Residual solvent contamination affects approximately 5% of recalls, primarily involving butane and propane residues in concentrate products exceeding 5,000 parts per million. These solvents are used in hydrocarbon extraction processes to produce shatter, wax, and other concentrate forms. Excessive residual solvents pose inhalation risks and can indicate inadequate purging during manufacturing. Ethanol and hexane are also monitored, with distinct action levels based on solvent toxicity profiles.

Market and Business Implications

Cannabis recalls impose significant financial costs on Colorado businesses while influencing operational practices, insurance markets, and investor confidence across the state's mature cannabis industry. Direct recall costs for cultivators and manufacturers range from $50,000 to $500,000 per event, depending on batch size and distribution scope. A typical recall affecting 50 pounds of flower at wholesale prices of $1,200 per pound represents $60,000 in destroyed inventory, plus additional costs for laboratory retesting, corrective action implementation, and regulatory compliance. Large-scale recalls affecting multiple batches can exceed $1 million in direct costs, creating existential threats for small operators with limited capital reserves. Indirect costs include reputational damage, lost retail shelf space, and strained relationships with downstream buyers. Dispensaries often reduce or eliminate purchases from cultivators with recall histories, preferring suppliers with consistent quality records. This market dynamic creates competitive advantages for vertically integrated operators who control cultivation, manufacturing, and retail operations, reducing third-party supply chain risks. The recall system has influenced the development of cannabis-specific insurance products. Standard commercial general liability policies typically exclude cannabis-related claims due to federal illegality, forcing operators to seek specialized coverage through surplus lines carriers. Product recall insurance for cannabis businesses carries premiums ranging from $5,000 to $25,000 annually, with coverage limits typically capped at $1 million per occurrence. Insurers require documented quality control systems, third-party testing, and integrated pest management plans as underwriting conditions. MSOs operating in Colorado have implemented sophisticated quality assurance programs to minimize recall risk. Schwazze, which operates approximately 20 dispensaries in Colorado, maintains an internal testing laboratory that supplements mandatory third-party testing, conducting additional screening before products reach retail shelves. This dual-testing approach increases costs by approximately 2-3% of revenue but reduces recall exposure and enhances brand reputation. The recall system has also influenced wholesale pricing dynamics. Cultivators with zero recall histories command premium pricing, typically 10-15% above market averages, as dispensaries value supply reliability and reduced regulatory risk. Conversely, cultivators with multiple recall events face pricing pressure and reduced market access, creating strong economic incentives for quality control investment. Capital markets have incorporated recall history into investment due diligence for Colorado cannabis companies. Private equity firms and institutional investors review MED recall databases during acquisition evaluations, with multiple recalls serving as red flags indicating operational deficiencies. Public MSOs with Colorado operations face additional scrutiny from securities analysts, who track recall frequency as a key performance indicator for operational excellence.

What Experts Say About Colorado's Recall System

Industry stakeholders, regulators, and public health experts offer varied perspectives on the effectiveness, challenges, and needed improvements for Colorado's cannabis recall framework. According to the MED's public statements, the recall system has successfully removed contaminated products from commerce while maintaining consumer confidence in regulated cannabis. The agency emphasizes that recall frequency reflects robust testing and enforcement rather than widespread safety failures, noting that Colorado's mandatory testing regime exceeds requirements in many newer cannabis markets. Testing laboratory directors have noted that improved analytical methods have increased contamination detection rates, particularly for pesticides present at trace levels. Laboratories now routinely detect compounds at concentrations below 0.1 parts per million, identifying contamination that would have gone undetected under earlier testing protocols. This enhanced sensitivity contributes to higher recall frequency but provides better consumer protection. Cultivator representatives have expressed concerns about inconsistent testing results between laboratories, citing instances where the same batch tests clean at one facility but fails at another. Industry groups including the Cannabis Business Alliance have advocated for enhanced proficiency testing and standardized methods to reduce inter-laboratory variability. Some operators argue that action levels for certain pesticides are overly conservative, particularly for compounds with low toxicity profiles. Patient advocacy organizations emphasize that recalls disproportionately affect medical marijuana users, who often face product shortages when popular strains are removed from dispensary shelves. Medical patients with specific strain preferences may experience treatment disruptions when recalled products represent their primary medicine. Advocates have called for enhanced consumer notification systems, including direct patient contact when transaction records allow identification of affected purchasers. Public health researchers have studied Colorado's recall data to identify contamination patterns and risk factors. A 2024 study published in the Journal of Cannabis Research found that smaller cultivation facilities (under 10,000 square feet) had recall rates approximately 40% higher than large-scale operations, suggesting that economies of scale support better quality control systems. The research also identified seasonal patterns, with microbial contamination recalls increasing during humid summer months. Regulatory experts from other states have praised Colorado's transparent recall database as a model for emerging markets. According to policy analysts, Colorado's public reporting system exceeds transparency standards in California, Michigan, and Illinois, where recall information is less accessible to consumers. The online database allows researchers, journalists, and advocates to track contamination trends and hold regulators accountable for enforcement consistency.

What's Next: Future Developments and Challenges

Colorado's cannabis recall system faces ongoing evolution as testing technology advances, market dynamics shift, and regulatory frameworks adapt to emerging challenges. The MED is developing enhanced testing requirements for emerging contaminants, including per- and polyfluoroalkyl substances (PFAS) and mycotoxins. PFAS compounds, known as "forever chemicals," have been detected in cannabis products in other states, raising concerns about contamination from agricultural inputs and packaging materials. The agency is expected to propose PFAS testing rules in late 2026, potentially adding new recall triggers and increasing compliance costs for cultivators. Mycotoxin testing represents another frontier for Colorado's recall system. While current regulations address total yeast and mold counts, they do not require specific testing for aflatoxins, ochratoxins, and other toxic fungal metabolites. Public health advocates have urged the MED to adopt mycotoxin action levels similar to those implemented in Oregon and Nevada, arguing that total microbial counts provide insufficient protection against specific toxic compounds. The state legislature is considering House Bill 26-1089, which would require dispensaries to maintain customer transaction records for 90 days and notify purchasers of recalled products via email or text message. The bill faces opposition from privacy advocates concerned about government-mandated customer tracking, but supporters argue that direct notification would enhance consumer protection, particularly for medical patients. Technological developments may transform recall procedures through blockchain-based tracking systems and rapid testing methods. Several Colorado companies are piloting blockchain integration with METRC, creating immutable records of product testing and distribution that could accelerate recall response times. Rapid testing technologies, including portable mass spectrometry devices, may eventually allow real-time contamination screening at cultivation facilities, catching problems before products enter the supply chain. The federal rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, finalized in 2025, may eventually influence Colorado's recall system through FDA involvement. While the FDA has not yet asserted jurisdiction over state-legal cannabis products, the agency's potential entry into cannabis regulation could establish federal testing standards and recall procedures that supersede state frameworks. Colorado regulators are monitoring federal developments while maintaining current state-level requirements. Climate change poses emerging challenges for contamination control, with increasing temperatures and humidity levels in Colorado creating conditions favorable for microbial growth. Cultivators are investing in enhanced environmental controls, including HVAC systems with humidity management and air filtration, to maintain optimal growing conditions and reduce contamination risk. The MED has scheduled a comprehensive review of pesticide action levels for late 2026, potentially updating thresholds based on new toxicological data and harmonizing standards with California and other major markets. Industry stakeholders anticipate that some action levels may be tightened while others could be relaxed, reflecting evolving scientific understanding of pesticide risks in cannabis products.

How Consumers Can Protect Themselves

Colorado cannabis consumers can take proactive steps to verify product safety, check recall status, and minimize exposure to contaminated products. The primary consumer protection tool is the MED's online recall database at colorado.gov/pacific/enforcement/med-marijuana-recalls. Consumers should check this database before consuming newly purchased products, searching by product name or batch number. Batch numbers are typically printed on product labels or packaging, often preceded by "Batch" or "Lot" designations. When purchasing cannabis products, consumers should verify that labels include required testing information, including the testing laboratory name, batch number, and test date. Products lacking this information may not have undergone mandatory testing and should be avoided. Consumers can also request certificates of analysis (COAs) from dispensaries, which provide detailed testing results for specific batches. Medical marijuana patients with compromised immune systems should exercise particular caution, avoiding flower products with visible mold or unusual odors. Concentrates and edibles generally pose lower microbial risks than flower due to processing steps that reduce microbial loads, though they remain subject to pesticide and solvent contamination. Consumers who experience adverse reactions after consuming cannabis products should report incidents to the MED through the agency's complaint system. Symptoms warranting reports include respiratory distress, severe nausea, neurological symptoms, or allergic reactions. Medical attention should be sought for serious symptoms, with healthcare providers encouraged to report suspected cannabis-related illnesses to the Colorado Department of Public Health and Environment. Purchasing from licensed dispensaries rather than unregulated sources provides the only access to tested products covered by the recall system. Unlicensed cannabis products carry unknown contamination risks and lack the consumer protections provided by Colorado's regulatory framework.

Further Reading and Primary Sources

• Colorado Marijuana Enforcement Division Official Recall Database: https://sbg.colorado.gov/med-recalls
• Colorado Marijuana Rules (1 CCR 212-3): https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=9526
• Colorado Revised Statutes Title 44, Article 10: https://leg.colorado.gov/sites/default/files/images/olls/crs-title-44.pdf
• Colorado Department of Revenue - Marijuana Enforcement Division: https://sbg.colorado.gov/med
• Amendment 64 Full Text: https://www.sos.state.co.us/pubs/elections/Initiatives/titleBoard/filings/2011-2012/30Final.pdf
• METRC Colorado Tracking System: https://co.metrc.com
• Colorado Department of Public Health and Environment - Medical Marijuana Registry: https://cdphe.colorado.gov/medical-marijuana
• Cannabis Business Alliance (Industry Association): https://cannabusinessalliance.org
• Colorado NORML: https://www.coloradonorml.org
• Journal of Cannabis Research (peer-reviewed studies): https://jcannabisresearch.biomedcentral.com

Update — June 2, 2026: Statewide THC Vape Recall Affects 320 Colorado Retailers

A major THC vape cartridge recall expanded to 320 licensed Colorado retailers in early June 2026, according to the Colorado Marijuana Enforcement Division. The recall targeted multiple product batches distributed between March and May 2026, affecting an estimated 15,000 individual vape units sold across the state's Front Range and mountain resort markets.

State regulators identified the contamination during routine compliance testing when samples exceeded allowable limits for residual solvents, specifically ethanol and propylene glycol, which can produce harmful byproducts when vaporized at high temperatures. The MED issued mandatory pull notices to all affected dispensaries on May 29, 2026, requiring immediate removal from shelves and consumer notification through point-of-sale systems. No hospitalizations were reported as of the recall announcement, though the state health department opened a monitoring protocol for adverse event reports.

The recall's scope represents one of Colorado's largest single-product safety actions since the 2019 statewide pesticide recalls. Affected retailers faced 72-hour compliance deadlines to document inventory removal and submit destruction manifests to the MED's seed-to-sale tracking system. Dispensaries that sold recalled products were required to post conspicuous signage and offer full refunds or product exchanges through June 30, 2026, creating immediate cash flow pressure for smaller operators already managing thin margins.

For Colorado's regulated market, the incident underscores ongoing challenges in vape cartridge manufacturing quality control. The state's testing protocols require pre-market screening for heavy metals, pesticides, and microbials, but solvent residue thresholds remain a frequent compliance failure point as manufacturers scale production. Consumer protection advocates said the recall demonstrates the value of Colorado's mandatory testing regime, which catches contamination before widespread health impacts occur, contrasting sharply with unregulated markets where similar products circulate without oversight.